T HE CURRENT ENVIRONMENT OF health care reform in the United States calls for increasing physician and hospital accountability and transparency of health care outcomes. 1 Surgical outcomes are usually assessed by mortality because it is an unambiguous outcome. For operations associated with low mortality, identifying outcomes that reflect the quality of care is challenging. [2] [3] [4] Breast-conserving therapy, or partial mastectomy, is one of the most commonly performed cancer operations in the United States. Current estimates suggest 60% to 75% of breast cancer cases undergo partial mastectomy as initial treatment. 5 Operative mortality estimates for partial mastectomy are less than 1%; however, low mortality does not necessarily equate to high quality. 4 Currently, there are no readily identifiable quality measures that allow for meaningful comparisons of breast cancer surgical outcomes among treating surgeons and hospitals.
Partial mastectomy is optimally performed by achieving adequate surgical margins during the initial surgical resection while maintaining maximum cosmetic appearance of the breast. Failure to achieve appropriate margins at the initial operation will require additional surgery with reexcision rate estimates ranging from 30% to 60%. [6] [7] [8] [9] These additional operations can produce considerable psychological, physical, and economic stress for patients and delay use of recommended adjuvant therapies. A high percentage (10%-36%) of women requiring reexcision undergo total mastectomy. Thus, the effect of reexcision on altering a patient's initial treatment of choice is significant. 7, [9] [10] [11] Our previous work demonstrated reexcision rates following initial partial mastectomy ranging between 11% and 25% among surgeons at a single high-volume university-based breast center. 3 We have expanded this analysis to include 3 additional geographically diverse health systems and their surgeons. We sought to measure variation in reexcision rates across hospitals and surgeons treating patients with similar clinical conditions. Furthermore, we explored whether patient demographic, clinical, and pathologic criteria were associated with an increased likelihood of reexcision following initial breast-conserving surgery for invasive breast cancer. The ability to define both predictors of reexcision and extent of variability should allow for full evaluation of the utility of reexcision as a meaningful measure of breast cancer surgery quality.
METHODS
We developed a Breast Cancer Surgical Outcomes (BRCASO) research consortium between the Cancer Research Network (CRN) and the University of Vermont. The CRN participating sites included Kaiser Permanente, Colorado; Group Health, western Washington state; and Marshfield Clinic, Wisconsin. The BRCASO cohort 12 includes women with breast cancer diagnosed between 2003 and 2008, and aged more than 18 years at diagnosis, whose initial breast cancer surgery was performed by a surgeon employed by a BRCASO study site, including any of the 3 participating CRN sites or Fletcher Allen Health Care Center, the sole hospital affiliated with the University of Vermont. We excluded men, patients with initial surgery performed by a surgeon outside the health care system where the reexcision was performed, and patients with breast cancer never treated surgically. Institutional review board approval was attained from all participating sites, and information from study participants was obtained via waiver of written informed consent. We collected detailed data regarding clinical features of initial breast cancer diagnosis, as well as highly detailed data regarding initial and all subsequent breast cancer surgeries performed on all patients. For this analysis, we only included patients with a final diagnosis of invasive ductal carcinoma or invasive lobular carcinoma who underwent initial breast conservation, either partial mastectomy or open breast biopsy as their first operative procedure for the incident breast cancer.
Data Collection
Trained medical abstractors with experience in breast cancer abstraction completed data collection via an exhaustive review of surgical, pathology, radiology, and surgeon and medical/oncology clinical evaluations. The data collection instrument included clinical factors (age, previous history of breast cancer), demographic factors (insurance status, race/ethnicity as reported by study participants in the medical record), disease characteristics (preoperative nodal status, preoperative estimated tumor size), and treatment characteristics (initial surgical procedure type) at the time of initial surgical treatment decision making and at subsequent surgeries. Data collection at the participating CRN sites, including race/ethnicity data, partially relied on the CRN's primary source of data infrastructure, the Virtual Data Warehouse and the availability of electronic medical records. 13 Data from the University of Vermont were entirely abstracted from medical records. The study focused on initial breast cancer surgery outcomes and did not evaluate utilization of radiation therapy, chemotherapy or hormonal therapy, or long-term outcomes such as local recurrence.
Surgical margin status was recorded for the initial breast-conserving procedure and for any subsequent excisions. Margins were categorized as positive if there was tumor at the inked margin in the pathology report. Histologic tumor type at closest or any positive margin was categorized as either invasive cancer or ductal carcinoma in situ (DCIS), when DCIS co-existed with invasive cancer. For negative margins, the distance of the closest margin to the specimen edge was recorded in 1-mm increments. For purposes of analyses, when distinct margin distances were recorded for the invasive component as well as DCIS, the smaller of the 2 distances was used. The anatomic orientation of the closest or positive margin was recorded when indicated in the pathology report. Margins categorized as radial included those recorded as superior, inferior, lateral, or medial. Anterior and posterior margins were categorized as such.
We established volume criteria for surgeons based on average yearly case volume for all initial breast cancer operations identified in the BRCASO database. The upper and lower thresholds for the 4 volume categories were defined at the first and third quartiles of volume for all operations, with the middle threshold set closer to the mean in order to have more meaningful differences in case volume between categories 1 and 2. We defined low surgeon volume as less than 10 incident breast cancer operations annually, intermediate surgeon volume as 10 to less than 25 operations annually, high surgeon volume as 25 to less than 50 operations annually, and very high surgeon volume as 50 or more operations annually.
Statistical Analysis
Bivariate analyses relating reexcision and clinical covariates were performed by using Pearson 2 tests of independence for categorical variables and t tests for quantitative variables. The Cochran-Armitage trend test was used for ordinal variables. Variables that were significant in the univariate analyses, those identified from a stepwise logis-VARIABILITY IN REEXCISION FOLLOWING BREAST CONSERVATION SURGERY tic regression model, and the variables of age and race/ethnicity were included in the multivariable random effects logistic regression model. Surgeons were entered as a random effect in the model and are nested within site, with no surgeon practicing in more than 1 site. This model was fit using maximum likelihood with adaptive quadrature.
14 P values are reported for 2-sided tests and are not adjusted for multiple comparisons. Significance was defined by PՅ.05. Confidence intervals are reported at the 95% level. Analyses were performed by using the FREQ, LOGISTIC, and GLIMMIX procedures in SAS version 9.2 (SAS Institute).
Surgeon-Level Analyses
Results for the median odds ratio (OR) and the range of ORs (ROR) are reported to quantify variability among surgeons on a scale that is directly comparable with that used for other variables in the study (ie, ORs). The median OR and ROR are based on the random effects variance component ( 2 ) from the logistic regression model. The median OR can be interpreted as the median value of the ratio of predicted odds of reexcision for 2 patients, randomly selected from different sites, with equivalent sets of covariates included in the reexcision model. In the model, the absolute difference between the log odds for 2 surgeons, with respect to reexcision, is a random variable following a half-normal distribution with variance 2 2 . The median OR is given by exp[ ͱ 2ϫϫ⌽ -1 (0.75)], where ⌽ is the cumulative distribution function for the standard normal distribution and ⌽ -1 (0.75) is the 75th percentile of the distribution. 15 The ROR is the ratio of the values at the 97.5th and 2.5th percentile of the distribution of ORs for individual surgeons. It represents a range of ORs because it is computed by exponentiation of the length of a 95% CI for the random effect variance component on the log-odds scale [ROR = exp(3.92ϫ), where 3.92 is 2 ϫ the 97.5th percentile of the standard normal distribution]. 16 The median OR and ROR provide measures of the outcome for a random effect that is directly comparable with the ORs used for fixed effects in the study. The majority of patients had a preoperatively established breast cancer diagnosis before the initial surgery, but for 109 patients (5.7%; 95% CI, 4.7%-6.8%) the initial procedure was an open surgical breast biopsy, which was associated with a marked increase in reexcision (45.0%; 95% CI, 35.6%- We analyzed the association between individual surgeon and the likelihood of reexcision in our multivariable analysis. The FIGURE demonstrates reexcision rates for individual surgeons, which ranged between 0% and 70%. This Figure demonstrates both observed reexcision rates and those rates predicted by the statistical model for the 54 surgeons who had at least 10 procedures meeting the inclusion criteria for our study. The predicted reexcision rates account for both clinical variables as well as patterns of reexcision at the individual surgeon's study site.
RESULTS

Overall
The overall surgeon level variance component was significant (P =.003).
The observed median OR of 1.59 (95% CI, 1.36-2.64) corresponds with the median value of the relative odds of reexcision between 2 randomly chosen surgeons from different sites. This indicates a relatively large individual surgeon effect, because half the ORs between 2 randomly chosen surgeons will be larger than 1.59. The range of ORs from the lower to the upper 2.5th percentile of the distribution is 6.8, indicating substantial heterogeneity among surgeons in reexcision.
COMMENT
Despite the significant physical, psychological, and financial effect of partial mastectomy reexcisions on patients, there remains a lack of standardization regarding its application among surgeons performing breast cancer surgery. Our results demonstrate an overall reexcision rate of 22.9% that is lower than previous studies demonstrating reexcision rates of 36% to 50%. 7, 11 Morrow et al 9 reported a reexcision rate following initial breast-conserving therapy of 37.9% in a similarly large series of 1459 patients, with 26.0% undergoing partial breast reexcision alone and 11.9% ultimately undergoing mastectomy. Our lower reexcision rate may be partially explained by our more extensive exclusion criteria, which were specifically chosen to select for patients considered most eligible for breast conservation. We excluded a significant number of women with preoperatively established multifocal breast cancer, a relative but not absolute contraindication for breast-conserving therapy.
In our study, the incidence of initial positive margins following breast conservation was 14.0%, which compares favorably with a similar cohort of 489 patients with invasive breast cancer undergoing initial breast conservation at a Canadian cancer center in which 26% of patients had initial positive margins. 10 Patients in that study had a preoperatively confirmed diagnosis of cancer in 69% of patients (vs 92.3% in our study, which likely contributed significantly to our lower initial positive mar- Abbreviations: DCIS, ductal carcinoma in situ; ER, estrogen receptor; PR, progesterone receptor.
VARIABILITY IN REEXCISION FOLLOWING BREAST CONSERVATION SURGERY
gin rate). We identified 14.1% of patients with positive margins in our study who did not undergo any reexcision. This finding is notable given that positive margins (tumor at inked margin) have been correlated with a long-term increased risk of local recurrence and are therefore almost uniformly reexcised. 17 A recent meta-analysis has suggested that the odds of local recurrence were 2.42 for women undergoing breast conservation with positive margins compared with negative margins. 18 Surveys among surgeons have also indicated consensus on the intent to reexcise positive margins following breast conservation. Our study may indicate that surgeon intent and actual clinical practice patterns do not necessarily have full correlation. We examined some clinical factors associated with reexcision and identified that surgeons were less likely to reexcise positive margins for invasive ductal carcinoma compared with invasive lobular carcinoma (83.07 vs 98.25%, P=.003). This may be due to the concern that invasive lobular cancer is often considered to have less distinct borders and may contribute to the greater tendency of reexcision of positive margins involving invasive lobular carcinoma.
We also observed variation in the reexcision of positive margins among institutions, with rates ranging between 73.7% and 93.5% (P = .003). This may reflect institutional variation in surgeons' training, regional variation in interpretation of the required criteria for reexcision, or both. Specific pathological features (eg, extent of intraductal component), clinical characteristics (eg, volume of breast tissue, intent for adjuvant radiation therapy), and patient decision making roles that may have influenced the decision not to reexcise a positive margin were not determined in our study. We assume that some of the variation may be explained by differences in the perceived risk of residual tumor based on the extent of margin positivity (eg, focally positive margins vs extensive involvement). The overall low number of patients with positive margins not undergoing reexcision precluded multivariable analysis.
Controversy regarding the necessity of reexcision for patients with pathologically clear margins exists because there is no current consensus on the appropriate distance required for a clear margin to be deemed adequate. [19] [20] [21] Although the goal of reexcision is to further reduce the risk of breast cancer recurrence and mortality, the true benefit of reexcision remains undetermined. Nearly half of reexcision specimens do not harbor residual cancer. 6, 11, 22 In our study, we found that 47.9% of patients with clear but less than 1.0-mm margins underwent reexcision, and 20.2% of patients with margins between 1.0 and 1.9 mm underwent reexcision.
These reexcision rates are considerably lower than would be predicted based on 3 recent surveys of practice patterns for close margins. [19] [20] [21] These surveys highlighted the inconsistency of reported practice patterns and physician interpretation of an acceptable margin distance. In the survey by Blair et al, 20 the majority of surgeons indicated more than 1-mm margins were required and a significant minority (30%) indicated a greater distance of 2-mm margins as acceptable. In the study by Azu et al, 21 when surgeons were given a scenario of a patient with a small (0.8 cm) invasive cancer, 11.2% accepted tumor not touching ink, 42% accepted 1-to 2-mm margins, 27.9% accepted at least 5-mm margins, and 18.9% desired more than 10-mm margins. Our study indicates that surgeons' actual clinical practices differ dramatically from these survey results. Although the Azu et al 21 survey study suggests a 5-mm margin is desired by 46% of surgeons, we identified 535 patients with 2.0-to 4.9-mm margins, only 26 (4.86%) of whom had reexcisions.
The effect of close but negative margins on local recurrence rates has not been conclusively determined and reexcision under these circumstances may or may not influence rates of recurrence. 17, 18 Some studies have shown an increase in local recurrence risk in the presence of close margins (Ͼ0-2 mm), while other studies have demonstrated no difference compared with widely negative margins. [23] [24] [25] Achieving greater margin distance (1 mm vs 2 mm vs 5 mm) was recently demonstrated in a meta-analysis to not be associated with differences in local recurrence rates, especially after adjusting for adjuvant therapy use. Additionally, based on survey reports, there appears to be variation in practice patterns among surgeons regarding the use of reexcision based on both margin distance and tumor histology present at the closest margin (DCIS vs invasive cancer). 19, 26 In light of the large number of new cases of breast cancer diagnosed each year in the United States (182 460 in 2008), this variation in surgical practice patterns could have an enormous outcome on health care costs nationwide (American Cancer Society, http://www.cancer .org/index). Given the current degree of practice variation we have demonstrated in the management of close margins, as well as the potential effect on both local recurrence and the number of additional surgical procedures, it is critical that we continue to understand actual clinical practice patterns beyond physician survey reports.
We identified that individual institutions vary significantly in reexcision rates, which to a large degree reflects the summation of individual surgeons' practice patterns at these institutions. Other factors behind institutional differences may represent utilization of multidisciplinary breast cancer teams, the reporting format and sectioning techniques of pathology teams, and perhaps even operative techniques of surgeons at various institutions.We did not examine institutional-specific factors that might contribute to differences in reexcision in our study, because our primary goal was to determine whether any significant differences existed.
Our finding that the median OR between 2 randomly selected surgeons was 1.6 suggests that patients under similar clinical conditions are likely to undergo reexcision based on the treating surgeon and not just the clinical characteristics. Possible explanations might include differences in surgical training, surgeon confidence in their operative technique in localizing tumors, utilization of intraoperative assessment of margins, and surgeon's and pathologist's coordination of specimen orientation and margin interpretation. Surgical experience may play a role, but we did not observe differences in reexcision rates between highand low-volume surgeons. Variability of what surgeons accept to be an adequate margin, as demonstrated by the aforementioned survey data, may therefore be a larger factor in the actual clinical variation in reexcision rates we observed.
The implications of variation in clinical practice of reexcision for positive and close margins warrants additional study, specifically as it relates to local recurrence health care costs and patients' perceived quality of health. We are aware of 1 recent comparative effectiveness study 27 that reported individual surgeon variation may contribute to long-term differences in breast cancer ipsilateral recurrence rates in patients with DCIS. Whether these findings would be similar for patients with invasive breast cancer warrants additional study.
A major limitation of our study is the absence of data regarding decision making factors influencing treatment options. For example, we do not know how patient preferences affect observed reexcision rates. Additionally, we were not able to control for factors such as specific pathology methods or reporting structure of breast cancer specimens. Our study, however, is likely more generalizable to community- based breast cancer management in which reporting of breast pathology also has considerable variability. 28 Not including local recurrence data limited our ability to evaluate any beneficial outcome of reexcisions. However, our primary focus was to explore variations in practice patterns for reexcision.
In conclusion, we found individual surgeons and institutions were associated with variation in reexcision rates following initial partial mastectomy for invasive breast cancer. This variability cannot be explained entirely by patients' clinical factors. Our study highlights the value of multicenter observational studies in demonstrating variability in health care across geographic regions and different health systems, with uniform data collection instruments. The long-term effect of this variability is beyond the scope of our study, but it is feasible that outcomes such as local recurrence and even overall survival could be affected by variability in initial surgical care. Even in the absence of effects on local control, the wide level of unexplained clinical variation itself represents a potential barrier to high-quality and costeffective care of patients with breast cancer. Continued comparative effectiveness research of breast cancer surgery requires further attention to better determine the association of initial surgical care with long-term patient outcomes.
